The functional significance of the soluble form of FcμR, an alternative splice variant skipping the TM exon, has just begun to be explored in diseases characterized by persistent BCR stimulation, such as CLL and antibody-mediated autoimmune disorders. Here, FCMR is linked to B-cell chronic lymphocytic leukemia.